TD Cowen Cuts Boston Scientific to Hold, Lowers Target to $46
TD Cowen cut its rating on Boston Scientific from Buy to Hold and lowered its target price from $56 to $46.
Related stories
South Korean Stocks Fall 3.5%, Down 16% This Month
South Korean shares closed down 3.5% Friday, bringing the month’s decline to 16%, as doubts about the global AI investment boom weighed on chipmakers.
M impact | EQUITY | Oct 30, 2026, 07:39 AM UTC
Ahold Delhaize to Acquire Tesco’s Czech and Slovak Operations
Ahold Delhaize will acquire Tesco’s operations in the Czech Republic and Slovakia.
M impact | EQUITY | Oct 30, 2026, 07:36 AM UTC
Varun Beverages Quarterly Profit Rises on Volume Growth
Packaging costs weighed on margins.
M impact | EQUITY | Oct 30, 2026, 07:35 AM UTC
Tesco Reports GBP2.9B Combined Sales in Czech Republic and Slovakia
M impact | EQUITY | Oct 30, 2026, 07:35 AM UTC
Panasonic Battery Unit Q2 Operating Profit Rises to 55.6 Billion Yen
Panasonic said operating profit at its energy unit rose from 1.2 billion yen a year earlier, citing higher sales of in-vehicle batteries and data centre energy storage systems. The
H impact | EQUITY | Oct 30, 2026, 07:35 AM UTC
Nikkei falls nearly 3% as technology shares retreat
The Nikkei fell nearly 3% as technology shares declined.
M impact | EQUITY | Oct 30, 2026, 07:34 AM UTC